*5000 participants per year were selected to participate in NHANES. The participants were interviewed and examined. UI concentration was measured on a random one third subsample of 2649 participants, aged 6 years and older in 2005-2006, and , and 56.9% AE 7.9% of this group had a UI concentration of <150 mg/L. UI concentrations were lower among nonHispanic black survey participants than non-Hispanic white and Mexican-American participants. Conclusions: These findings affirm the stabilization of UI concentration and adequate iodine nutrition in the general U.S. population since 2000. However, certain groups likely do not achieve a sufficient dietary iodine intake according to the World Health Organization. The needs of these vulnerable groups and the inadequacy of their dietary iodine intake should be addressed in future efforts.
Introduction
T he sufficiency of the dietary iodine intake for the general U.S. population has been monitored since 1971 through the National Health and Nutritional Survey (NHANES) (1) (2) (3) . Iodine is necessary in the synthesis of thyroid hormones, which are essential for normal growth, development, and metabolism throughout life. During gestation and lactation, women have an enhanced requirement for iodine to support the development of the fetus and newborn. The most damaging effect of iodine deficiency is inadequate thyroid hormone supply to the developing brain. Thyroid hormone is particularly important for myelination of the central nervous system, which is most active during fetal and early postnatal development.
Iodized salt and seafood are the major dietary sources of iodine, although dairy and grain products are the primary sources of iodine in the American diet (4) . In the United States, salt is iodized with potassium iodide, which is used by about 50%-60% of the U.S. population. However, the U.S. population receives only a small percentage of its salt from table salt because *70% of dietary salt is derived from processed food, which uses mostly noniodized salt (5) . Urinary iodine (UI) concentrations directly reflect dietary iodine intake because >90% of consumed iodized salt appears in the urine. Thus, the UI concentration is recommended for assessing a population's iodine status worldwide (6) .
UI excretion is often expressed as a concentration (mg/L) or in relation to creatinine excretion (mg iodine/g creatinine). In populations with adequate general nutrition, the UI concentration correlates well with the UI/creatinine ratio. The World Health Organization (WHO) defines nutritional iodine sufficiency for a population by UI concentrations as follows: excessive iodine intake, >300 mg/L; more than adequate intake, 200-299 mg/L; adequate intake, 100-199 mg/L; mild iodine deficiency, 50-99 mg/L; moderate iodine deficiency, 20-49 mg/L; and severe iodine deficiency, <20 mg/L (6) . WHO recently increased the recommended iodine intake for pregnant women from 200 to 250 mg/day, and suggested that a median UI concentration of 150-249 mg/L indicates dietary iodine sufficiency in this group (6) . The Food and Nutrition Board of the Institute of Medicine reported age-specific recommended dietary allowances (RDA) for iodine intake for specific age groups and for pregnant and lactating women (7) . For example, the RDA for iodine is 90 mg/day for children and 150 mg/day for adults. For pregnant women, the RDA increases to 220 mg/day. The daily iodine intake can be estimated from the UI concentration after making assumptions for the 24-hour urine volume and a 92% gut bioavailability for iodine (7) .
The findings from the 2007-2008 NHANES, which is the largest assessment of the general U.S. population's iodine sufficiency status to date, demonstrate that the dietary intake of iodine by the population has remained at an adequate and stable level since 2000. In addition, children aged 6-11 years continue to exceed the nutritional requirement for iodine, women have a higher prevalence of dietary iodine insufficiency than men, and non-Hispanic black Americans have a lower UI concentration than non-Hispanic white and Mexican-Americans. These findings indicate that the assessment of a population's dietary iodine requirement should be comprehensive and cannot be based solely on the status of iodine sufficiency in school-aged children because vulnerable groups such as pregnant women exist within the population. A comprehensive sampling of pregnant women can provide improved estimates of the prevalence of iodine sufficiency in this country.
Subjects and Methods

Study design
NHANES is conducted by the National Center for Health Statistics at the Centers for Disease Control and Prevention (CDC). NHANES uses a stratified, multistage design to provide a representative probability sample of the civilian, noninstitutionalized population of the United States, aged 2 months and older. The surveys in this report were conducted from January has been published elsewhere. These surveys included an interview conducted at the household and an examination at a mobile examination center. The examination consisted of a variety of physical measurements and blood and urine collections. For the 2005-2006 survey, annual UI concentrations were measured in one third of *5000 people aged 6 years and older who had been selected to represent the U.S. population for the survey. For the 2007-2008 survey, annual UI concentrations were measured in all of the *5000 participants aged 6 years and older. Each stage of the sample selection was randomized to ensure unbiased representative estimates for the U.S. population. A detailed description of the data collection methods for NHANES has already been published (8,9) and will not be presented here.
Demographic variables
Sociodemographic data were self-reported by study participants during the interview. Information included individual characteristics such as sex, age, self-reported race and ethnicity, years of education completed, and household income information. Participants were grouped by age: children (6-11 years), adolescents (12-19 years) , and adults (!20 years). Similarly, a race/ethnicity variable was derived from self-reported questionnaire data, resulting in four categories of race/ethnicity: non-Hispanic white, nonHispanic black, Mexican-American, and other remaining races/ethnicities.
Pregnancy variable
Pregnant women in the survey were identified in a retrospective manner. A urine pregnancy test was used to screen women aged 12-59 years to exclude pregnant participants from a dual-energy X-ray absorptiometric scan during the physical examination. Trimester information was selfreported by study participants, and this information was 
Laboratory methods
During the physical examinations, spot urine specimens were collected from participants, and aliquots of these specimens were generated and stored cold (28C-48C) or frozen until shipped. Samples collected for UI measurement were shipped on dry ice to CDC's National Center for Environmental Health (NCEH) and were stored frozen (À708C) for <1 year. Samples were analyzed for UI concentration using the method of Caldwell et al. (10) . Briefly, 0.5 mL of urine was diluted 1:10 with 1% (v/v) tetramethylammonium hydroxide, 0.02% Triton X-100Ô, 25 mg/L tellurium (Te), 5 mg/L bismuth (Bi), 5% (v/v) ethanol, 1000 mg/L gold, and 0.5 g/L EDTA. This solution was subsequently analyzed using inductively coupled plasma dynamic reaction cell mass spectrometry as previously described (2, 10) . Iodine was quantified based on the peak as a ratio of analyte to internal standard tellurium. Two concentration levels of quality controls were analyzed in each analytical batch with unknown samples. Reported results met the accuracy and precision specification of the quality control/quality assurance program of the Division of Laboratory Sciences, NCEH, CDC (11) . During the analysis of UI for this study, these two quality control pools were analyzed multiple times (n ¼ 445), and they had a relative standard deviation of 2.79% at 93 mg/L iodine and 2.60% at 308 mg/L iodine. Absolute assay accuracy was verified by the blind analysis of two additional iodine reference solutions and the analysis of National Institute of Standard Technology (NIST) 2670A Standard Reference Material.
In healthy populations, creatinine is excreted from the body at a relatively constant rate over time, and expressing iodine results per gram of creatinine can help correct for the effect of urinary dilution. The UI concentration is presented as ''per volume of urine'' and ''per gram of creatinine'' in this report because these are the common approaches used to represent the value. Urinary creatinine concentrations were determined by using an automated colorimetric method on a Beckman Korn and Graubard (14) . In linear regression models, SUDAN PROC REGRESS was used to calculate the adjusted geometric means and their CIs. In the initial model, the main effects of urinary creatinine, sex, and racial/ethnic group were explored. Urinary creatinine was the only continuous variable considered. Separate models were considered for each age group. Adjusted geometric means were provided for all significant ( p < 0.05) main effects. Women of childbearing age were aged 15-44 years. When sample sizes for a given subpopulation or group are small, the results must be interpreted with caution because they have large standard errors (15).
Results
UI concentration
The general U.S. In both survey periods, the median UI demonstrated a U-shaped distribution by age because it was higher at the age extremes than at the middle years, such as 20s-40s (Table 1) . Also, non-Hispanic black participants had a lower ( p < 0.05) UI concentration than non-Hispanic white and Mexican-American participants in all age groups after adjusting for sex and/or urinary creatinine (Supplementary Tables S1 and S2 Table S3 ).
Iodine sufficiency
The prevalence of iodine insufficiency (UI <100 mg/L) in the general U.S. population was 28.2 % AE 1.1% in 2007-2008 (Table 3 ). The proportions of the population with UI concentrations <50 and <20 mg/L were 8.8% AE 0.4% and 1.1% AE 0.2%, respectively. Children aged 6-11 years had a prevalence of 17.0% AE 1.3% for iodine insufficiency, and 5.4% AE 1.0% of them had a UI concentration <50 mg/L. The prevalence of iodine insufficiency appears to be highest during the third, fourth, and fifth decades of life (Table 3) Table S4 ).
In 2007-2008, the percent of women aged 6 years and older with a UI concentration <100 mg/L was lower in MexicanAmerican than in non-Hispanic black and non-Hispanic white participants (Table 3) . This difference among race/ ethnic groups in women was also observed at UI concentrations <50 mg/L and <20 mg/L. In male participants aged 6 years and older, the percent with a UI concentration <100 mg/L was higher in non-Hispanic black than in nonHispanic white and Mexican-American participants (Table 3) . However, this observation in male participants was not noted at lower UI concentrations.
In the combined 2005-2006 and 2007-2008 dataset, the prevalence of iodine insufficiency was 38.3% AE 1.9% in nonpregnant women of childbearing age and 56.9% AE 7.9% in pregnant women (Table 2 ). These estimates of prevalence corresponded to *29.5 million nonpregnant and 1.9 million pregnant women. The percentage of nonpregnant women of childbearing age with a UI concentration of <50 mg/L was 14.8% AE 1.7%, or *7.6 million women.
The percent of the population with a UI concentration of !200 mg/L or above the level for adequate requirement varied by age and race/ethnicity based on 2007-2008 data (Table 4) . In non-Hispanic black and non-Hispanic white participants, children and older adults appeared to have higher prevalences of UI concentrations !200 mg/L than young adults. For example, 35.9% AE 4.2% of non-Hispanic black girls aged 6-11 years and 45.5% AE 9.4% women aged 70 years and older had UI concentrations !200 mg/L; 18.8% AE 4.1% of those aged 20-29 years had UI concentrations !200 mg/L. Thus, the distribution of the prevalence of UI concentration !200 mg/L by age in these race/ethnicities was U-shaped, which is consistent with the observation for the median UI concentration for the general population (Table 1 ). In Mexican-American participants, this pattern was observed in male subjects but not in female subjects. For example, 46.6% AE 4.0%, 33.4% AE 6.4%, and 33.2% AE 9.2% of Mexican-American female subjects aged 6-11 years, 20-29 years, and 70 years and older had a UI concentration of !200 mg/L, respectively.
Discussion
The general U.S. population in 2007-2008 was nutritionally iodine sufficient based on a median UI concentration of 164 mg/L (95% CI 154-174) and a prevalence of 8.8% AE 0.4% had a UI concentration <50 mg/L. In addition, these findings indicate that the dietary iodine intake of the general population has remained stable since 2000 because these indicators of iodine sufficiency have remained essentially unchanged in the last three U.S. surveys (2, 3) . However, variations in the status of dietary iodine sufficiency exist among groups in the population. For example, children aged 6-11 years are slightly above the requirement for adequate iodine nutrition (!200 mg/L), and pregnant women are slightly iodine insufficient. Pregnant women have a median UI concentration of (16) (17) (18) . Thus, comprehensive assessments of iodine sufficiency in the general population should be continued because of differences in dietary iodine intake among groups in the population. Enhanced efforts are needed to adequately represent the nutritional iodine sufficiency of pregnant women in the U.S. population because of their small sample size in these surveys. The 2007-2008 NHANES for iodine sufficiency is the largest assessment of the general U.S. population to date, and the findings in this report support the observations from past surveys.
Children
The level of nutritional iodine among U.S. children aged 6-11 years has been above the adequate requirement level since 1998 based on WHO's epidemiologic criteria that use UI measurements (1) (2) (3) 19) . This status indicates that the dietary iodine intake for children in this age group is higher than the RDA, which ranges from 90 mg/(person Á day) (aged 4-8 years) to 120 mg/(person Á day) (aged 9-13 years) (7). This observation is consistent with the assessment conducted in 2003-2004 by the U.S. Food and Drug Administration's Total Diet Study (TDS) on the dietary intake of iodine in the population (4). Based on the TDS, the average (lower and upper bounds of the estimate) total iodine intakes for children aged 6-11 years were 255-280 mg/(person Á day) and 276-304 mg/ (person Á day), respectively. These estimates exceeded the daily requirements at these ages. Dairy and grain products were the major iodine sources for these children. These recent estimates of the daily iodine food intake in children are similar to those from the TDS conducted in 1991-1997 (7). In the earlier assessment, the median (standard error) values for the total daily iodine intake for children aged 4-8 years, male subjects (9-13 years), and female subjects (9-13 years) were as follows: 270 mg/(person Á day) (0.01), 330 mg/(person Á day) (0.01), and 270 mg/(person Á day) (0.01). Thus, the findings from the TDS on the dietary intake of iodine support reports of greater than sufficient UI concentration levels in children in NHANES since 1998. Knowledge on the long-term effects of excess iodine administration to children is limited. Children exposed to an elevated iodine concentration (462 mg/L) in drinking water in China had a higher prevalence of goiter than those exposed to drinking water with a lower concentration (54 mg/L) (65% vs. 15%) (20) . Although these children were euthyroid and had an unremarkable neurologic exam, the goiter was attributed to a hypofunctioning thyroid (i.e., lower triiodothyronine, higher thyroxine [T4], and higher thyrotropin [TSH]) based on comparative thyroid function tests among these two exposure groups. An assessment of 19 counties in China demonstrated a median UI concentration >900 mg/L in the population, a mean water iodine concentration >300 mg/L, and a >10% prevalence of euthyroid goiter in these counties (21) . The subacute thyroidal effects in children from the exposure to iodide are less apparent. When children were administered 80 mg of potassium iodide per day for 3 months for prophylaxis from the nuclear reactor criticality event at Chernobyl, they had an elevated TSH concentration that lasted for *2 weeks (22) .
The clinical consequence of high iodine intake is hypothyroidism or hyperthyroidism resulting from the body's inability to completely regulate the iodine load, a problem that occurs in a small percent of the population and is typically associated with an underlying thyroid disorder (22, 23) . Persons with an underlying autoimmune thyroid disorder appear susceptible to iodine-induced hypothyroidism. When dietary iodine intake was restricted among Japanese study participants with hypothyroidism who were taking >200 mg/ (person Á day) of iodine, thyroid function tests normalized in the group with negative thyroid autoantibodies (microsomal and thyroglobulin antigens) and remained abnormal in the group with positive titers (24) . A slight increase in the incidence of hypothyroidism in the population was observed during a monitoring period when Denmark instituted a mandatory iodine fortification of 50 mg/(person Á day) (25) . The incidence rate of hypothyroidism, based on TSH and T4 concentrations, at 1 and 3 years after iodine fortification was instituted increased from baseline by a factor of 1.27 and 1.23, respectively. Persons in the population with moderate iodine deficiency who were affected most were adults aged 20-59 years. No increased incidence in hypothyroidism was observed in children and adolescents during the monitoring period.
Pregnant women
The dietary iodine sufficiency of women of childbearing age in the United States appears to have remained stable since 2001 based on the median UI concentration and the 26) . A larger sampling of pregnant women that is representative by race/ethnicity can provide a more stable estimate of the iodine sufficiency for this group in the general population than the current survey. Also, this information can strengthen the recommendation to pregnant women for iodine supplementation during pregnancy to maintain sufficient iodine stores in the body (27) . The health risk to the fetus from maternal iodine insufficiency is greatest during the first trimester because the fetus is reliant upon maternal iodine stores for thyroid hormone synthesis. A maternal median UI concentration 50 mg/L during the first half of gestation can cause thyroid abnormalities such as increased thyroid gland size and elevated TSH and thyroglobulin concentrations in the newborn (28, 29) . Also, a maternal UI concentration >50 mg/L during the second trimester, an increased thyroglobulin, and a decreased free T4 index can cause thyroid abnormalities in the newborn (30, 31) . Iodine supplementation during pregnancy can ameliorate these effects in the newborn (28, 29) . Also, iodine supplementation can decrease the prevalence of postpartum goiter from iodine deficiency caused by gestation and lactation (32, 33) . The Food and Nutrition Board of the Institute of Medicine recommends an iodine intake of 220 mg/(person Á day) for pregnant women (7) . This dose approximates a UI concentration of 150 mg/L. In 2006, the American Thyroid Association recommended that pregnant women take an iodine supplement of 150 mg/day because the lower limit of the 95% CI for the median UI concentration estimate for pregnant women in the 2003-2004 NHANES was below the recommended value (27) . The findings in this report support this decision and the need for an improved assessment of the iodine sufficiency of pregnant women in the United States.
IODINE STATUS OF THE U.S. POPULATION, 2005-2008
Nonpregnant women of childbearing age with low iodine sufficiency can also benefit from iodine supplementation because some of them may not be aware that they are in the early stages of pregnancy-a time when iodine sufficiency is extremely important. During 2005-2008 NHANES, an estimated 29.5 million women in this category had UI concentrations below the WHO recommendation for iodine sufficiency. Among these women, an estimated 76.2 million had UI concentrations <50 mg/L. Also, iodine supplementation before pregnancy compared with iodine supplementation during pregnancy appears to decrease a woman's risk for abnormal thyroid function tests (i.e., decreased free T4 and increased TSH) (34) . Thus, the likelihood for thyroid abnormalities among newborns can be reduced by preventing the occurrence of maternal thyroid abnormalities due to iodine insufficiency (27) (28) (29) .
The relation between UI concentration and thyroid function in American pregnant women was studied using NHANES III data (35) . These pregnant women had a median UI concentration of 140.5 mg/L (95% CI 124.3-180.2) and a prevalence of 6.9% AE 1.9% for a UI concentration <50 mg/L. Also, the prevalence for TSH >4.5 mL/UI was 1.3% AE 1.1% in these women. In this cross-sectional study, no significant relation was found between UI concentration, TSH, and T4 (35) . A low UI concentration in these women was not associated with hypothyroidism as defined by serum TSH and T4 concentrations. These observations are consistent with those from other studies (36, 37) and suggest that pregnant women in the United States are mildly iodine insufficient. However, an improved survey design for pregnant women is recommended to confirm these findings.
The 2007-2008 survey is the largest sampling of the U.S. population to assess nutritional iodine sufficiency by using UI concentration. The significance of this large survey is the ability to characterize vulnerable groups in the population who may be difficult to evaluate because of their small sample size. This factor contributes to an improved assessment of the overall population for a country. WHO has historically based a country's nutritional iodine status on the UI concentration from school-aged children and used such data to estimate global iodine sufficiency. In the 2007-2008 NHANES, children aged 6-11 years have more than adequate levels of iodine in their diets as demonstrated by their median UI concentration of 215 mg/L and the small prevalence of 3.9% for a UI concentration <50 mg/L. If the country's iodine status was based only on this information, the iodine status of pregnant women would not be recognized. The median UI concentration of pregnant women in 2005-2008 was 125 mg/L, and 56.9% of them had a UI concentration <150 mg/L. These data indicate that pregnant women in the United States appear to be at a slight risk for iodine insufficiency; however, a representative sampling of pregnant women is needed to confirm the implication. Further, a national survey on school-aged children cannot be used to represent a country's nutritional iodine status because other vulnerable groups in the population likely have a different nutritional iodine status. Thus, a comprehensive assessment of the population is necessary to characterize the nutritional iodine status of a country properly.
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